191 related articles for article (PubMed ID: 33986418)
1. A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3).
Rivas DR; Dela Cerna MVC; Smith CN; Sampathi S; Patty BG; Lee D; Blackburn JS
Sci Rep; 2021 May; 11(1):10302. PubMed ID: 33986418
[TBL] [Abstract][Full Text] [Related]
2. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
3. Structure of the Complex of an Iminopyridinedione Protein Tyrosine Phosphatase 4A3 Phosphatase Inhibitor with Human Serum Albumin.
Czub MP; Boulton AM; Rastelli EJ; Tasker NR; Maskrey TS; Blanco IK; McQueeney KE; Bushweller JH; Minor W; Wipf P; Sharlow ER; Lazo JS
Mol Pharmacol; 2020 Dec; 98(6):648-657. PubMed ID: 32978326
[TBL] [Abstract][Full Text] [Related]
4. Targeting PRL phosphatases in hematological malignancies.
Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
[TBL] [Abstract][Full Text] [Related]
5. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells.
Min G; Lee SK; Kim HN; Han YM; Lee RH; Jeong DG; Han DC; Kwon BM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3769-74. PubMed ID: 23726031
[TBL] [Abstract][Full Text] [Related]
6. The dual inhibition against the activity and expression of tyrosine phosphatase PRL-3 from a rhodanine derivative.
Lin L; Lu L; Yuan C; Wang A; Zhu M; Fu X; Xing S
Bioorg Med Chem Lett; 2021 Jun; 41():127981. PubMed ID: 33766767
[TBL] [Abstract][Full Text] [Related]
7. Structure and backbone dynamics of vanadate-bound PRL-3: comparison of 15N nuclear magnetic resonance relaxation profiles of free and vanadate-bound PRL-3.
Jeong KW; Kang DI; Lee E; Shin A; Jin B; Park YG; Lee CK; Kim EH; Jeon YH; Kim EE; Kim Y
Biochemistry; 2014 Jul; 53(29):4814-25. PubMed ID: 24983822
[TBL] [Abstract][Full Text] [Related]
8. Next-Generation Cell-Active Inhibitors of the Undrugged Oncogenic PTP4A3 Phosphatase.
Lazo JS; Blanco IK; Tasker NR; Rastelli EJ; Burnett JC; Garrott SR; Hart DJ; McCloud RL; Hsu KL; Wipf P; Sharlow ER
J Pharmacol Exp Ther; 2019 Dec; 371(3):652-662. PubMed ID: 31601683
[TBL] [Abstract][Full Text] [Related]
9. Protein-tyrosine phosphatase 4A3 (PTP4A3) promotes vascular endothelial growth factor signaling and enables endothelial cell motility.
Zimmerman MW; McQueeney KE; Isenberg JS; Pitt BR; Wasserloos KA; Homanics GE; Lazo JS
J Biol Chem; 2014 Feb; 289(9):5904-13. PubMed ID: 24403062
[TBL] [Abstract][Full Text] [Related]
10. Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783.
Tian W; Qu L; Meng L; Liu C; Wu J; Shou C
BMC Biochem; 2012 Oct; 13():22. PubMed ID: 23092334
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma.
Mayinuer A; Yasen M; Mogushi K; Obulhasim G; Xieraili M; Aihara A; Tanaka S; Mizushima H; Tanaka H; Arii S
Ann Surg Oncol; 2013 Jan; 20(1):305-17. PubMed ID: 23064776
[TBL] [Abstract][Full Text] [Related]
12. PRL-3/PTP4A3 phosphatase regulates integrin β1 in adhesion structures during migration of human ocular melanoma cells.
Foy M; Anézo O; Saule S; Planque N
Exp Cell Res; 2017 Apr; 353(2):88-99. PubMed ID: 28284838
[TBL] [Abstract][Full Text] [Related]
13. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.
Slørdahl TS; Abdollahi P; Vandsemb EN; Rampa C; Misund K; Baranowska KA; Westhrin M; Waage A; Rø TB; Børset M
Oncotarget; 2016 May; 7(19):27295-306. PubMed ID: 27036022
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.
Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Watanabe M
Int J Cancer; 2010 Aug; 127(3):543-54. PubMed ID: 19960436
[TBL] [Abstract][Full Text] [Related]
15. Targeting phosphatases of regenerating liver (PRLs) in cancer.
Wei M; Korotkov KV; Blackburn JS
Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
[TBL] [Abstract][Full Text] [Related]
16. The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia.
Zhou J; Cheong LL; Liu SC; Chong PS; Mahara S; Bi C; Ong KO; Zeng Q; Chng WJ
Mol Cancer; 2012 Sep; 11():72. PubMed ID: 22995644
[TBL] [Abstract][Full Text] [Related]
17. Investigational inhibitors of PTP4A3 phosphatase as antineoplastic agents.
Sharlow ER; Wipf P; McQueeney KE; Bakan A; Lazo JS
Expert Opin Investig Drugs; 2014 May; 23(5):661-73. PubMed ID: 24625356
[TBL] [Abstract][Full Text] [Related]
18. Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2.
Duciel L; Anezo O; Mandal K; Laurent C; Planque N; Coquelle FM; Gentien D; Manneville JB; Saule S
Sci Rep; 2019 Feb; 9(1):2990. PubMed ID: 30816227
[TBL] [Abstract][Full Text] [Related]
19. Effect of Pharmacological Inhibition of the Catalytic Activity of Phosphatases of Regenerating Liver in Early T Cell Receptor Signaling Dynamics and IL-2 Production.
Aguilar-Sopeña O; Hernández-Pérez S; Alegre-Gómez S; Castro-Sánchez P; Iglesias-Ceacero A; Lazo JS; Roda-Navarro P
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260565
[TBL] [Abstract][Full Text] [Related]
20. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
